University of Perugia
Perugia, 06100, Italy
NCT Number: NCT00576004
To evaluate the impact of Burch colposuspension (BC), as an anti-incontinence measure, in patients with urinary incontinence (UI) undergoing abdominal surgery for pelvic organ prolapse (POP) repair
Looking for future studies?
Notify Me18 year–75 year
Female
Interventional
Not applicable
Perugia, 06100, Italy
Forty-seven women suffering from POP and UI were randomly assigned to abdominal POP repair and concomitant BC ( 24 patients; group A) or POP repair alone without any anti-incontinence procedure ( 23 patients.; group B). They were followed-up at 3, 6, and 9 months after surgery and then annually. The primary outcome measures were anatomical outcome and changes in incontinence status as indicated by a bladder diary, the number of daily pads and the stress test. Secondary endpoints were changes in subjective symptoms and Quality of Life (QoL) as measured by the Urogenital Distress Inventory (UDI-6) and the Impact Incontinence Quality of Life (IIQ-7) questionnaires.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Abdominal pelvic organ prolapse repair and retropubic Burch colposuspension
Time frame: 2002-2006
Time frame: 2002-2206
University Of Perugia
Other
Pelvic Organ Prolapse Repair With or Without Concomitant Burch Colposuspension in Patients With Urinary Incontinence: A Randomised Surgical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05312047
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Badalona, Barcelona, Spain
View Trial DetailsNCT01632839
Behavior, Digestive System Diseases
Clamart, France
View Trial DetailsNCT06210477
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Taipei, Taiwan
View Trial DetailsNCT05567900
Behavior, Behavior, Health
Pécs, Baranya, Hungary
View Trial Details